Researchers Submit Patent Application, "Blood Cell Analyzer, Method For Indicating Infection Status And Use Of Infection Marker Parameter", for Approval (USPTO 20240353310).

Researchers have submitted a patent application for a blood cell analyzer that aims to evaluate infection status, including sepsis, in patients. The device uses novel blood cell morphological parameters to provide early prediction, diagnosis, and monitoring of infections, without requiring additional testing costs. The patent application focuses on improving the accuracy and timeliness of diagnosing infectious diseases, such as sepsis, using existing blood cell analyzers. [Extracted from the article]